| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Epidemiology of asthma.
|
Int Arch Allergy Immunol
|
2005
|
0.91
|
|
2
|
Pharmacologic control of asthma.
|
Int Arch Allergy Immunol
|
2005
|
0.91
|
|
3
|
Time trend in the prevalence of adult asthma in Japan: findings from population-based surveys in Fujieda City in 1985, 1999, and 2006.
|
Allergol Int
|
2011
|
0.85
|
|
4
|
A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
|
Allergol Int
|
2006
|
0.84
|
|
5
|
Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: a double-blind, placebo-controlled study.
|
Respirology
|
2007
|
0.82
|
|
6
|
Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma.
|
Respirology
|
2009
|
0.81
|
|
7
|
Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma.
|
Respirology
|
2007
|
0.80
|
|
8
|
Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
|
Allergol Int
|
2012
|
0.80
|
|
9
|
Effects of nebulized sodium cromoglycate on adult patients with severe refractory asthma.
|
Respir Med
|
2005
|
0.78
|
|
10
|
Definition, diagnosis, disease types, and classification of asthma.
|
Int Arch Allergy Immunol
|
2005
|
0.78
|
|
11
|
One year treatment with omalizumab is effective and well tolerated in Japanese Patients with moderate-to-severe persistent asthma.
|
Allergol Int
|
2010
|
0.77
|
|
12
|
Prospective survey on safety evaluation of injectable methylxanthines in Japan.
|
Allergol Int
|
2006
|
0.77
|
|
13
|
[History of my study on allergy of 15 years as a physician].
|
Arerugi
|
2009
|
0.75
|
|
14
|
[Special project "improvement of the Japanese Society of Allergology and Medical Treatment for Allergic Disease"].
|
Arerugi
|
2006
|
0.75
|
|
15
|
Terumasa Miyamoto. Tokyo, Japan.
|
Chem Immunol Allergy
|
2014
|
0.75
|
|
16
|
[Retrospective thoughts on studies of allergy and collagen disease in the 20th Century and prospects for the 21st Century (discussion)].
|
Nihon Naika Gakkai Zasshi
|
2002
|
0.75
|
|
17
|
[Progress in the study of allergy and collagen disease in the last 100 years: Concept of allergy].
|
Nihon Naika Gakkai Zasshi
|
2002
|
0.75
|
|
18
|
[Cost-effectiveness of salmeterol/fluticasone combination therapy vs. fluticasone propionate in Japanese asthmatic patients].
|
Yakugaku Zasshi
|
2010
|
0.75
|
|
19
|
Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
|
Curr Med Res Opin
|
2010
|
0.75
|